PMC:7556165 / 31744-31888
Annnotations
LitCovid-sample-sentences
{"project":"LitCovid-sample-sentences","denotations":[{"id":"T196","span":{"begin":0,"end":144},"obj":"Sentence"}],"namespaces":[{"prefix":"_base","uri":"http://pubannotation.org/ontology/tao.owl#"}],"text":"The phenotype was dramatically improved and rescued either administering ACE2 recombinant analogs or AT1Ra inhibitors (Imai et al., 2005, 2008)."}
LitCovid-sample-Pubtator
{"project":"LitCovid-sample-Pubtator","denotations":[{"id":"859","span":{"begin":73,"end":77},"obj":"Gene"}],"attributes":[{"id":"A859","pred":"pubann:denotes","subj":"859","obj":"Gene:70008"}],"text":"The phenotype was dramatically improved and rescued either administering ACE2 recombinant analogs or AT1Ra inhibitors (Imai et al., 2005, 2008)."}
LitCovid-sample-UniProt
{"project":"LitCovid-sample-UniProt","denotations":[{"id":"T2513","span":{"begin":73,"end":77},"obj":"Protein"}],"attributes":[{"id":"A2513","pred":"uniprot_id","subj":"T2513","obj":"https://www.uniprot.org/uniprot/Q9UFZ6"}],"text":"The phenotype was dramatically improved and rescued either administering ACE2 recombinant analogs or AT1Ra inhibitors (Imai et al., 2005, 2008)."}
LitCovid-PubTator
{"project":"LitCovid-PubTator","denotations":[{"id":"859","span":{"begin":73,"end":77},"obj":"Gene"}],"attributes":[{"id":"A859","pred":"tao:has_database_id","subj":"859","obj":"Gene:70008"}],"namespaces":[{"prefix":"Tax","uri":"https://www.ncbi.nlm.nih.gov/taxonomy/"},{"prefix":"MESH","uri":"https://id.nlm.nih.gov/mesh/"},{"prefix":"Gene","uri":"https://www.ncbi.nlm.nih.gov/gene/"},{"prefix":"CVCL","uri":"https://web.expasy.org/cellosaurus/CVCL_"}],"text":"The phenotype was dramatically improved and rescued either administering ACE2 recombinant analogs or AT1Ra inhibitors (Imai et al., 2005, 2008)."}
LitCovid-sentences
{"project":"LitCovid-sentences","denotations":[{"id":"T196","span":{"begin":0,"end":144},"obj":"Sentence"}],"namespaces":[{"prefix":"_base","uri":"http://pubannotation.org/ontology/tao.owl#"}],"text":"The phenotype was dramatically improved and rescued either administering ACE2 recombinant analogs or AT1Ra inhibitors (Imai et al., 2005, 2008)."}